Current financial headlines
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
Chronological news
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …
Sharemaestro market context Trend signal active 52 weeks +9.1%DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …
Sharemaestro market context Trend signal active 52 weeks +9.1%Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Teledyne Technologies (NYSE: TDY) agreed to acquire Varex Imaging for US$1.1b, expanding its X ray and CT detector portfolio. The deal adds photon …
Jeremy Hayden, an insider at Sight Sciences, Inc. (SGHT), has filed a Form 144 detailing planned sales of common stock through Fidelity Brokerage Services LLC. The filing also reports prior restricted stock vestings from January 2024, March 2024, and a scheduled vesting in January …
DexCom (DXCM) has raised its 2026 revenue and margin outlook following a strong second quarter, shifting focus towards profitability. The company's G7 15 Day rollout is contributing to improved gross margins and manufacturing efficiency. Despite the positive outlook, potential foreign exchange headwinds, manufacturing investments, …
Sharemaestro market context Trend signal active 52 weeks +9.1%DexCom (DXCM) shares have surged 52.5% in the last three months, outperforming major benchmarks, driven by strong Q2 2026 earnings and improved margins. While the company's fundamental performance is robust with revenue growth and margin expansion, its premium valuation necessitates consistent execution to justify …
Sharemaestro market context Trend signal active 52 weeks +9.1%Insulet reported strong Q2 2026 results with 23% revenue growth and increased profitability, driven by demand for Omnipod. However, the company lowered its full-year revenue outlook due to lower-than-anticipated retention and utilization rates among Type 2 diabetes customers, particularly in the initial 90 days …
AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 4.99% in Haemonetics Corp (HAE) common stock. This position, totaling 2,266,489 shares, was reported in a Schedule 13G/A filing as of June 30, 2026. The entities …
BrainsWay Ltd. (BWAY) reported Q2 2026 financial results, meeting profit expectations with diluted EPS of $0.07 and beating revenue estimates with $17.1M. The company's Deep TMS technology drove a 35% revenue surge year-over-year, shipping 125 systems in the quarter, and set full-year revenue guidance …
The Abbott Big Ten $1 Million Blood Drive returns for its third year, with Nebraska aiming to reclaim the title from Wisconsin. The competition, which runs from August 26th to December 4th, encourages donations to help address a national blood crisis, with a $1 …
PROCEPT BioRobotics (NASDAQ:PRCT) shares fell 4.8% after reporting mixed Q2 2026 results with revenue growth but a larger-than-expected loss and continued unprofitability. The company faces a class-action lawsuit regarding alleged misleading statements about demand and inventory, adding to investor uncertainty. Despite a CEO stock …
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach …
Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …
Sharemaestro market context Price above Trend Line 52 weeks -4.1%MaxCyte, Inc. (MXCT) reported a Q2 loss of $0.08 per share, exceeding the Zacks Consensus Estimate of a $0.12 loss, and surpassed revenue estimates with $7.27 million. Despite beating earnings and revenue expectations in some recent quarters, the stock has underperformed the market this …
Glaukos Corp (GKOS) stock has reached an all-time high of $184.45, reflecting a 100.01% increase over the past year and a 41.55% revenue surge in Q2 2026. Despite an InvestingPro analysis suggesting the stock may be overvalued, 11 analysts have revised earnings upwards, indicating …
IceCure Medical Ltd Q2 2026 Earnings Call Summary - Moby Strategic Performance and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …
CeriBell is expanding its brainwave-monitoring platform beyond seizure detection, introducing new products for delirium and pediatric patients, and eventually stroke. The company's technology offers faster, more accessible EEG monitoring in acute care settings, supported by AI-powered detection algorithms. CeriBell aims to grow its hospital …
Mobia Medical (MOBI) is positioned for long-term growth due to its Vivistim Paired VNS therapy for stroke recovery, targeting a large and underserved patient population. Analysts project significant revenue growth of 50.3% annually over the next three years, expecting the company to reach profitability …
Bank of America Corporation has reported a beneficial ownership of 3.5% in Outset Medical, Inc., holding 666,596 shares of common stock. This stake, representing a shared voting and dispositive power, is held through several of its wholly-owned subsidiaries. The filing indicates that Bank of …
AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 6.44% in Inspire Medical Systems, Inc. (INSP) through a Schedule 13G filing. The AQR entities collectively own 1,856,800 shares, with shared voting power over 1,783,224 shares …
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief IR and Communications Officer - Julie Dewey President and Chief Executive Officer - Massimo Calafiore Chief Financial Officer - Julie Andrews Full Conference Call Transcript Operator: Thank …
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates. This upgrade suggests an improvement in the company's underlying business and could lead to a favorable impact on its stock price. The Zacks Rank …
Ceribell has received FDA 510(k) clearances for two AI enhancements integrated into its cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction. These tools aim to improve the diagnosis of epilepsy and streamline the interpretation of EEGs by automatically highlighting abnormal brain wave patterns …
BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, successful integration of acquired home health assets and a scalable home-based care platform. However, the Inflation Reduction Act (IRA)-related …
CVRx Inc. has announced the departure of its chief revenue officer following a reduction in its full-year revenue guidance. The company attributes the lowered outlook to employee turnover and productivity issues, which have impacted sales of its primary product, Barostim, a device for heart …
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own …
NeuroPace (NPCE) reported strong second-quarter 2026 results, with earnings and revenues surpassing Zacks Consensus Estimates, driven by significant growth in its RNS System. The company also raised its full-year 2026 revenue guidance and improved its adjusted EBITDA loss outlook. NeuroPace highlighted advancements in AI-based …
Sharemaestro market context Price below Trend Line 52 weeks +64.3% · Next-week setup positive 57.8%Bill Shields, a long-time Medtronic executive specializing in transcatheter mitral and tricuspid therapies, has been appointed CEO of Versa Vascular. Versa Vascular is a startup developing a minimally invasive transcatheter device called AdapTR to treat tricuspid valve regurgitation. Shields' appointment comes as Versa Vascular …
BofA Securities has maintained its Hold rating on Beta Bionics (BBNX.US) and increased its target price for the company's stock to $18. This adjustment reflects BofA's updated outlook for Beta Bionics.
LivaNova reported record Q2 2026 revenue of $390.6 million and adjusted diluted EPS of $1.26, exceeding prior-year figures, driven by strong demand in Cardiopulmonary and Epilepsy segments. The company raised its full-year 2026 revenue guidance to 8%-9% growth and adjusted diluted EPS guidance to …
Search by ticker symbol or company name and select a result to open its chart.